Group One Trading
IMVT icon

Group One Trading’s Immunovant IMVT Stock Holding History

Group One Trading’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Sell
4,800
-7,400
-61% -$192K ﹤0.01% 4576
2025
Q4 		$310K Sell
12,200
-17,700
-59% -$395K ﹤0.01% 3979
2025
Q3 		$482K Buy
29,900
+16,300
+120% +$264K ﹤0.01% 3750
2025
Q2 		$218K Sell
13,600
-97,500
-88% -$1.47M ﹤0.01% 4252
2025
Q1 		$1.9M Buy
111,100
+15,900
+17% +$333K 0.01% 1859
2024
Q4 		$2.36M Buy
95,200
+17,200
+22% +$488K 0.01% 1772
2024
Q3 		$2.22M Buy
78,000
+9,200
+13% +$271K 0.01% 1636
2024
Q2 		$1.82M Sell
68,800
-2,000
-3% -$56.9K 0.01% 1530
2024
Q1 		$2.29M Sell
70,800
-84,100
-54% -$3.07M 0.01% 1392
2023
Q4 		$6.53M Sell
154,900
-151,100
-49% -$5.56M 0.02% 940
2023
Q3 		$11.7M Buy
306,000
+265,700
+659% +$6.01M 0.04% 442
2023
Q2 		$764K Buy
40,300
+28,000
+228% +$522K ﹤0.01% 2605
2023
Q1 		$191K Buy
12,300
+1,400
+13% +$24.3K ﹤0.01% 3725
2022
Q4 		$193K Sell
10,900
-88,600
-89% -$1.12M ﹤0.01% 3891
2022
Q3 		$555K Sell
99,500
-32,000
-24% -$156K ﹤0.01% 3133
2022
Q2 		$513K Buy
131,500
+107,500
+448% +$464K ﹤0.01% 3397
2022
Q1 		$132K Buy
24,000
+22,000
+1,100% +$137K ﹤0.01% 5229
2021
Q4 		$17K Sell
2,000
-32,300
-94% -$267K ﹤0.01% 7058
2021
Q3 		$298K Buy
34,300
+800
+2% +$7.22K ﹤0.01% 4751
2021
Q2 		$354K Buy
33,500
+9,600
+40% +$134K ﹤0.01% 4598
2021
Q1 		$383K Buy
+23,900
New +$630K ﹤0.01% 4349

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Group One Trading's IMVT Position: Q1 2026 in Review

Group One Trading increased its Immunovant (IMVT) stake by 356% in Q1 2026, buying an estimated $416K and bringing the position to 20,586 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #3325.

Group One Trading first reported a position in IMVT in Q1 2021 and has held it in 17 quarters since. The position peaked at $5.79M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Group One Trading held 20,586 shares of Immunovant worth $511K as of Q1 2026.
  • Group One Trading bought 16,074 Immunovant shares in Q1 2026, an estimated $416K.
  • Immunovant made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3325 holding.
  • Group One Trading first reported a position in Immunovant in Q1 2021 and has held it in 17 quarters since.
  • Group One Trading's Immunovant position peaked at $5.79M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.